<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>OAR@UM Collection:</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/3608</link>
    <description />
    <pubDate>Wed, 08 Apr 2026 04:12:37 GMT</pubDate>
    <dc:date>2026-04-08T04:12:37Z</dc:date>
    <item>
      <title>Late presentation and successful treatment of classical scimitar syndrome</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/3953</link>
      <description>Title: Late presentation and successful treatment of classical scimitar syndrome
Authors: Grech, Victor E.; Xuereb, R.; Xuereb, M.; Manche, Alexander; Schembri, K.; DeGiovanni, Joseph V.
Abstract: Scimitar syndrome is a form of partial anomalous pulmonary venous drainage that is&#xD;
dramatically visible on plain chest radiography (CXR). In these individuals the entire&#xD;
venous drainage from the right lung enters a single anomalous large vein that&#xD;
descends to the inferior vena cava. This descending vein is visible on CXR as a&#xD;
curvilinear density along the right heart border and resembles the curved Turkish&#xD;
sword that gives the condition its name. Scimitar syndrome forms part of the large&#xD;
spectrum of associated conditions known as venolobar syndrome. These include&#xD;
right lung hypoplasia or sequestered segments of right lung, congenital heart disease&#xD;
and various others. We report the case of a young woman who presented&#xD;
incidentally, with a murmur, at 16 years of age. Full investigation including&#xD;
angiography showed a large atrial septal defect with right heart dilation and scimitar&#xD;
syndrome. She underwent surgical correction with uneventful and complete&#xD;
correction by baffling of the scimitar vein from its entry into the inferior vena to the left&#xD;
atrium through the enlarged atrial septal defect.</description>
      <pubDate>Wed, 01 Jan 2003 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/3953</guid>
      <dc:date>2003-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The use of anticoagulation in pediatric cardiac disease</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/3941</link>
      <description>Title: The use of anticoagulation in pediatric cardiac disease
Authors: Boris, Jeffrey R.; Harris, Matthew A.
Abstract: Palliation and repair of increasingly complex congenital heart defects as well as the&#xD;
emergence of novel contexts has led to multiple scenarios in which a real or potential&#xD;
risk of thromboembolism may exist. While various anticoagulation methodologies&#xD;
have been well defined for adults, there are few studies relating directly to pediatric&#xD;
patients. This article reviews a number of specific pediatric disease states, the&#xD;
representative pediatric literature, and, where appropriate, the corresponding adult&#xD;
literature. In so doing, the art and science of pediatric cardiac anticoagulation is&#xD;
defined with the hope to engender further thought regarding future directions of study&#xD;
and therapy.</description>
      <pubDate>Wed, 01 Jan 2003 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/3941</guid>
      <dc:date>2003-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A review of congenital heart block</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/3940</link>
      <description>Title: A review of congenital heart block
Authors: Friedman, Deborah M.; Glickstein, J.; Duncanson, L.J.; Buyon, Jill P.
Abstract: Congenital heart block is a rare disorder. It has an incidence of about 1 in 22,000 live&#xD;
births. It may be associated with high mortality and morbidity. This should generate a&#xD;
high index of suspicion for early diagnosis and aggressive therapy when appropriate.&#xD;
The congenital heart block associated with neonatal lupus is considered a form of&#xD;
passively acquired autoimmune disease in which maternal autoantibodies to the&#xD;
intracellular ribonucleoproteins Ro (SS-A) and La (SS-B), cross the placenta and&#xD;
injure the previously normal fetal heart. Women with serum titers of anti-Ro antibody&#xD;
carry a 3% risk of having a child with neonatal lupus syndrome. Recurrence rates are&#xD;
about 18%. We believe that serial echocardiograms should be acquired so that early&#xD;
diagnosis is made and aggressive therapy administered, if signs of conduction&#xD;
system disease such as PR interval prolongation by Doppler are found, so as to&#xD;
optimize the outcome. Establishment of guidelines for therapy have been set&#xD;
empirically, should signs of congenital heart block develop. Those patients whose&#xD;
congenital heart block is associated with structural heart disease have a higher&#xD;
morbidity and mortality, which is determined more by the underlying structural&#xD;
congenital heart disease than it is by the need for a pacemaker per se.</description>
      <pubDate>Wed, 01 Jan 2003 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/3940</guid>
      <dc:date>2003-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

